- Home
- HQI vs ACHV Comparison
HQI vs ACHV Comparison
Compare HQI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HQI | ACHV |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.5M | 167.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HQI | ACHV |
|---|---|---|
| Price | $7.88 | $4.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $13.00 | ★ $15.50 |
| AVG Volume (30 Days) | 32.9K | ★ 599.1K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.04% | N/A |
| EPS Growth | ★ 412.84 | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $31,691,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.17 | N/A |
| P/E Ratio | $15.20 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.52 | $1.84 |
| 52 Week High | $15.75 | $5.78 |
Technical Indicators
Market Signals| Indicator | HQI | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 43.19 | 52.73 |
| Support Level | $7.52 | $4.57 |
| Resistance Level | $8.36 | $4.97 |
| Average True Range (ATR) | 0.60 | 0.31 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 26.63 | 57.31 |
Price Performance
Historical ComparisonAbout HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.